Identification of C-glycoside analogues that display a potent biological activity against murine and human invariant natural killer T cells

AUTOR(ES)

Li, Xiangming

FONTE

Blackwell Science Inc

RESUMO

We have recently shown that α-C-galactosylceramide (α-C-GalCer) stimulates invariant natural killer T (iNKT) cells and preferentially induces a T helper 1 (Th1)-type response in mice. However, α-C-GalCer was found to be a rather weak ligand against human iNKT cells in vitro. Therefore, in this study, we sought to identify a compound that displays a strong stimulatory activity against human iNKT cells, by determining the biological activities of several C-glycoside analogues. From the in vitro screening assays, we found that almost all C-glycoside analogues, which have an E-alkene linker between sugar and lipid moieties, are able to activate human iNKT cells and to induce the maturation and activation of human dendritic cells through iNKT-cell activation. In summary, although α-galactosylceramide (α-GalCer) remains the strongest iNKT-cell ligand, our study identified E-alkene-linked C-glycoside analogues as potent human iNKT-cell stimulants, and indicated that these analogues could be used as a therapeutic agent in the future for diseases resolved by Th1-type responses.

Documentos Relacionados

• Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans.
• Characterization of intestinal absorption of C-glycoside flavonoid vicenin-2 from Lychnophora ericoides leafs in rats by nonlinear mixed effects modeling
• Deficiency of invariant natural killer T cells in coeliac disease
• Invariant Natural Killer T Cells and TGF-β Attenuate Anti-GBM Glomerulonephritis
• Invariant natural killer T cells in asthma and COPD: back to square one!